Login
$SPTX
$19.12 -$0.86 (4.3%) Live

Insider Transactions

What Seaport Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 1 3
Sells 0 0
Total trades 2 17

Shares traded

3 months 12 months
Acquired 5,000 25,571,137
Disposed 100,000 100,000
Net activity −95,000 +25,471,137

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Zohar Daphne Chief Executive Officer Nov 10 Gift · G −100,000 — — 1,094,001
Torres Denice Director Nov 03 Open-market buy · P +5,000 $19.87 +$99.3K 5,000
Hombach Robert J. Director Jun 22 Open-market buy · P +13,000 $18.14 +$236K 13,000
Paul Steven M Director May 04 Derivative Conversion · C +67,031 — — 863,031
Arch Venture Partners XII, Llc 10% owner May 04 Open-market buy · P +1,100,000 $18.00 +$19.8M 6,294,951
Arch Venture Partners XII, Llc 10% owner May 04 Derivative Conversion · C +2,681,265 — — 5,194,951
Arch Venture Partners XII, Llc 10% owner May 04 Derivative Conversion · C +2,513,686 — — 2,513,686
Healy James Director May 04 Derivative Conversion · C +804,379 — — 2,731,538
Healy James Director May 04 Derivative Conversion · C +1,927,159 — — 1,927,159
White Lauren Chief Financial Officer May 04 Derivative Conversion · C +6,702 — — 6,702
Torres Denice Director May 04 Derivative Conversion · C +13,406 — — 13,406
Chen Michael Cunyuan Chief Scientific Officer May 04 Derivative Conversion · C +3,351 — — 3,351
Loebel Antony Chief Medical Officer May 04 Derivative Conversion · C +20,109 — — 20,109
Gladstein Lana General Counsel May 04 Derivative Conversion · C +33,515 — — 33,515
PureTech Health plc 10% owner May 04 Derivative Conversion · C +965,255 — — 16,685,013
PureTech Health plc 10% owner May 04 Derivative Conversion · C +2,681,265 — — 15,719,758
PureTech Health plc 10% owner May 04 Derivative Conversion · C +12,736,014 — — 13,038,493

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support